Vanguard Group’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $2.2M | Buy |
|
|||||
|
2022
Q4 | $1.43M | Sell |
|
|||||
|
2022
Q3 | $2.58M | Buy |
|
|||||
|
2022
Q2 | $3.87M | Buy |
|
|||||
|
2022
Q1 | $2.85M | Sell |
|
|||||
|
2021
Q4 | $6.29M | Sell |
|
|||||
|
2021
Q3 | $12.4M | Buy |
|
|||||
|
2021
Q2 | $22.8M | Buy |
|
|||||
|
2021
Q1 | $30.3M | Buy |
|
|||||
|
2020
Q4 | $35.1M | Buy |
|
|||||
|
2020
Q3 | $22.1M | Buy |
|
|||||
|
2020
Q2 | $7.87M | Buy |
|
|||||
|
2020
Q1 | $3.77M | Buy |
|
|||||
|
2019
Q4 | $6.83M | Buy |
|
|||||
|
2019
Q3 | $6.99M | Buy |
|
|||||
|
2019
Q2 | $1.07M | Buy |
|